Skip to main content
. 2024 Aug 21;44(10):1975–1986. doi: 10.1007/s00296-024-05685-3

Table 1.

Patient demographics and clinical data

Diagnosis
RA (n = 26) PsA (n = 24) Control subject (n = 26)
Age [years]
 Mean 52.7 46.3 48.4
 Standard deviation 16.1 12.8 11.9
Sex
 Female 9 (34.6%) 14 (58.3%) 14 (53.8%)
 Male 17 (65.4%) 10 (41.7%) 12 (46.2%)
BMI [kg/m2]
 Mean 25.1 26.9 27.0
 Standard deviation 4.1 5.3 4.1
Smoking
 Neversmoker 17 (65.4%) 14 (58.3%) 19 (73.1%)
 Eversmoker 9 (34.6%) 10 (41.7%) 7 (26.9%)
Chronic cough
 No 16 (61.5%) 19 (79.2%) 24 (92.3%)
 Yes 10 (38.5%) 5 (20.8%) 2 (7.7%)
Dyspnea
 No (NYHA I) 20 (76.9%) 19 (79.2%) 24 (92.3%)
 Yes (NYHA II +) 6 (23.1%) 5 (20.8%) 2 (7.7%)
Previous pulmonary disease
 No 23 (88.5%) 22 (91.7%) 22 (84.6%)
 Bronchial asthma 2 (7.7%) 1 (4.2%) 1 (3.8%)
 COPD 0 (0.0%) 0 (0.0%) 1 (3.8%)
 Sarcoidosis 0 (0.0%) 1 (4.2%) 2 (7.7%)

Table 1 presents the epidemiological and disease-related characteristics of the study population, according to their rheumatological diagnosis

RA rheumatoid arthritis, PsA psoriatic arthritis, NYHA New York Heart Association, BMI Body Mass Index, COPD chronic obstructive pulmonary disease